Evidence map›Paper›PMID 42212238›Full record

ArticleFrontiers in RNA research2023

Roles of ribosomal RNA in health and disease.

Ryan Johnston, Anne Aldrich, Shawn M Lyons

Abstract read
In one paragraph

Article in Frontiers in RNA research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. RiboScreenBiomedicines · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Impacts of ribosomal RNA sequence variation on gene expression and phenotype.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryan JohnstonDepartment of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Anne AldrichDepartment of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Shawn M LyonsDepartment of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston, MA, United States.

Funding

Regulation of Ribosome BiogenesisR35GM146769 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Shawn M Lyons · 2022 to 2026
$2.0M
NIGMS NIH HHS R35 GM146769
6 · The paper itself

Abstract

Ribosomes are amongst the most ancient molecular machines in cells, showing conservation from the simplest prokaryotes to humans. Ribosomes are an assembly of ribosomal (r)RNA and ribosomal proteins, but the rRNA comprises most of the mass of the ribosome and performs key enzymatic tasks. In humans, rRNA undergoes a laborious maturation that involves multiple processing steps and the deposition of chemical modifications. The correct processing and modification of rRNA ensures the proper function of the mature ribosome. Disturbance of these processes may lead to human disease. Understanding the role of rRNA in protein synthesis and the consequences of its dysregulation is key to deciphering and mitigating the emergence of pathological states in human biology.

Indexed as

protein synthesisribosomeribosomopathyrRNAtranslation

Identifiers

PMID42212238
PMCPMC13215694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.